# Metformin Therapy in Non-diabetic AAA Patients

Study · id `cardio:ct-nct03507413` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03507413](<https://clinicaltrials.gov/study/NCT03507413>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03507413

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

## Technical summary

Registry record NCT03507413. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-26 (actual); primary completion 2024-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 170 participants (planned count; ClinicalTrials.gov record NCT03507413, source copy `cardio:ctgov-nct03507413-2024-03-28`, retrieved 2026-11-18)
- Started: 2018-09-26 (actual) (ClinicalTrials.gov record NCT03507413, source copy `cardio:ctgov-nct03507413-2024-03-28`, retrieved 2026-11-18)
- Primary completion: 2024-05-01 (anticipated) (ClinicalTrials.gov record NCT03507413, source copy `cardio:ctgov-nct03507413-2024-03-28`, retrieved 2026-11-18)
- Completion: 2024-05-01 (anticipated) (ClinicalTrials.gov record NCT03507413, source copy `cardio:ctgov-nct03507413-2024-03-28`, retrieved 2026-11-18)
- Countries: Austria (ClinicalTrials.gov record NCT03507413, source copy `cardio:ctgov-nct03507413-2024-03-28`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03507413-2024-03-28`, retrieved 2026-11-18)

## The registry's words

- Brief title: Metformin Therapy in Non-diabetic AAA Patients
- Acronym: MetAAA
- Condition: Abdominal Aortic Aneurysm
- Intervention (Drug): Metformin Glucophage 500mg (IR) tablets M90
- Intervention (Drug): Placebo Oral Tablet
- Lead sponsor: Medical University of Vienna
- Lead sponsor class: OTHER
- Collaborator: Merck Serono GmbH, Germany
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Medical University of Vienna (`cardio:org-medical-university-of-vienna`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake-A Double-Blind, Randomized, and Placebo-Controlled Trial (`cardio:pubmed-41283274`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7b63c0fe0821b9f5315989a08c8960bce53126aafdc2769e5ce2f1a62e25ab1f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
